UA122333U - THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug - Google Patents

THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug

Info

Publication number
UA122333U
UA122333U UAU201711173U UAU201711173U UA122333U UA 122333 U UA122333 U UA 122333U UA U201711173 U UAU201711173 U UA U201711173U UA U201711173 U UAU201711173 U UA U201711173U UA 122333 U UA122333 U UA 122333U
Authority
UA
Ukraine
Prior art keywords
antimicrobial
composition
fungal
drug
keratolytic
Prior art date
Application number
UAU201711173U
Other languages
Ukrainian (uk)
Inventor
Олександр Іванович Тихонов
Олег Сергійович Шпичак
Оксана Євгенівна Фролова
Original Assignee
Олександр Іванович Тихонов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олександр Іванович Тихонов filed Critical Олександр Іванович Тихонов
Priority to UAU201711173U priority Critical patent/UA122333U/en
Publication of UA122333U publication Critical patent/UA122333U/en

Links

Abstract

Склад лікарського препарату протигрибкової, протимікробної та кератолітичної дії, містить діючу речовину нафтифіну гідрохлориду. Додатково містить настоянку прополісу, хлорхінольдол, саліцилову кислоту.The composition of the drug antifungal, antimicrobial and keratolytic action, contains the active substance naphthine hydrochloride. Additionally contains propolis tincture, chloroquinoldol, salicylic acid.

UAU201711173U 2017-11-15 2017-11-15 THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug UA122333U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201711173U UA122333U (en) 2017-11-15 2017-11-15 THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201711173U UA122333U (en) 2017-11-15 2017-11-15 THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug

Publications (1)

Publication Number Publication Date
UA122333U true UA122333U (en) 2017-12-26

Family

ID=60955962

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201711173U UA122333U (en) 2017-11-15 2017-11-15 THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug

Country Status (1)

Country Link
UA (1) UA122333U (en)

Similar Documents

Publication Publication Date Title
NZ742208A (en) Topical pharmaceutical formulations for treating inflammatory-related conditions
BR112016026291A2 (en) BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
CR20200158A (en) Multispecific antigen-binding molecule having blood coagulation factor viii (fviii) cofactor function-substituting activity, and pharmaceutical formulation containing said molecule as active ingredient
BR112017026650A2 (en) antifungal methylobacterium compositions and methods of use
NI201500135A (en) PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
PL417066A1 (en) Arginase inhibitors and their therapeutical applications
CL2016001918A1 (en) Heteroaryl amides as protein aggregation inhibitors
PE20160052A1 (en) PHARMACEUTICAL COMPOSITION OF S-CETAMINE HYDROCHLORIDE
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
CO2017010065A2 (en) Injectable extended release formulations comprising an active isoxazoline agent
EA201791910A1 (en) INJECTABLE PREPARATIONS OF LONG-TERM ACTIONS CONTAINING ISOXASOLINE EXISTING SUBSTANCE, METHODS AND APPLICATIONS
DOP2017000307A (en) ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARATION OF THE SAME.
CO2017007316A2 (en) Pharmaceutical formulation
KR20220035954A (en) Pharmaceutical composition comprising an antifungal drug as an active ingredient
CY1122979T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNGIASIS
BR112018016715A2 (en) oritavancin formulations?
DK3906016T3 (en) LIQUID PROPOLIS EXTRACT, FORMULATION AND USES THEREOF
UY34189A (en) FUNGICIDE BLENDS THAT INCLUDE ISOXAZOL AND OTHER ACTIVE INGREDIENT.
BR112017024126B8 (en) PHARMACEUTICAL COMPOSITIONS, MICRONIZED COMPOUND A AND/OR AT LEAST ONE MICRONIZED PHARMACEUTICALLY ACCEPTABLE SALT OF COMPOUND A AND USE THEREOF
CO2018011420A2 (en) Liquid phosphaplatin formulations
EA201692493A1 (en) ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS WITH THE ABILITY TO INHIBIT MULTIPLE DOSE SUSTAINABILITY
UA122333U (en) THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug
MA44859A (en) OXAZOLINE PSEUDODIMERS, PHARMACEUTICAL COMPOSITIONS AND RELATED USE
UA117330C2 (en) THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug
UA116755C2 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF suppositories with early healing, anti-erosion, anti-inflammatory, anti-microbial, anti-fungal, immunostained and immunostained